"
Q76 - Pulmonary Hypertension — Classification, Pathophysiology & Perioperative Management
Q76 · Paper II · 10 MARKS · Long Answer
Pulmonary Hypertension — Classification, Pathophysiology & Perioperative Management
Question: Define pulmonary hypertension and describe its WHO classification [2]. Explain the pathophysiology of right ventricular failure in pulmonary hypertension [4]. Outline the specific anaesthetic goals and management for a patient with severe pulmonary hypertension presenting for non-cardiac surgery [4].
Core ConceptPulmonary hypertension (PH) — mPAP ≥20 mmHg at rest — carries perioperative mortality of 7–24% for major non-cardiac surgery. The right ventricle is catastrophically vulnerable to acute afterload increases. Understanding RV physiology and the triggers of RV failure is key to safe anaesthetic management.
A. Definition & WHO Classification2 marks
Definition (ESC/ERS 2022): mPAP ≥20 mmHg at right heart catheterisation; PAH (Group 1) additionally requires PVR >2 Wood units AND PAWP ≤15 mmHg (pre-capillary).
| WHO Group | Mechanism | Examples |
|---|
| Group 1 – PAH | Smooth muscle hypertrophy + intimal proliferation + in-situ thrombosis → ↑PVR (pre-capillary) | Idiopathic PAH; scleroderma (highest risk); Eisenmenger; drug-induced |
| Group 2 – Left heart disease | ↑LA pressure → pulmonary venous hypertension (post-capillary) | LV failure; mitral stenosis; constrictive pericarditis |
| Group 3 – Lung disease/hypoxia | Hypoxic pulmonary vasoconstriction → chronic ↑PVR | COPD; ILD; OSA; high-altitude PH |
| Group 4 – CTEPH | Unresolved PE → organised thrombus → mechanical obstruction | Complicates 2–4% of acute PE; surgically curable |
| Group 5 – Multifactorial | Heterogeneous | Haemolytic anaemia, sarcoidosis, fibrosing mediastinitis |
B. Pathophysiology of RV Failure4 marks
- Normal RV: thin-walled, low pressure (~25 mmHg), high compliance chamber; tolerates volume but not sudden afterload.
- Chronic adaptation: ↑PVR → concentric RVH → ↓compliance → ↑RVEDP → systemic venous hypertension.
- RV–PA uncoupling: RV Emax cannot match rising Ea → RV dilates → ↑wall stress → ↑O₂ demand → subendocardial ischaemia.
- Coronary perfusion – the critical vulnerability: once RV systolic pressure ≥ aortic diastolic pressure, RV is perfused only in diastole (like the LV) → dependent on DBP.
- Ventricular interdependence (death spiral): ↑PVR → RV dilates → D-shaped septum → ↓LV filling → ↓CO → ↓DBP → ↓RV perfusion → RV ischaemia → further ↓CO.
Key Anaesthetic Goals – ""Prevent the RV Failure Death Spiral""Avoid: ↑PVR (hypoxia, hypercapnia, acidosis, hypothermia, pain) · Avoid ↓systemic BP (maintain RV coronary perfusion) · Avoid ↓HR · Maintain RV preload without overload · Optimise RV contractility.
C. Anaesthetic Goals & Management4 marks
| Goal | Intervention |
|---|
| ↓PVR | FiO₂ ≥0.6, normoventilation (PaCO₂ 35–40), warming, analgesia, PEEP ≤5, avoid N₂O, continue PH therapy |
| Pulmonary vasodilators | Inhaled NO 10–40 ppm; inhaled iloprost/epoprostenol; IV sildenafil; milrinone (inodilator) |
| Maintain systemic BP | Vasopressin or phenylephrine preferred (↑SVR w/o ↑PVR); avoid vasodilators/high spinal |
| RV contractility | Dobutamine, milrinone, adrenaline, levosimendan; avoid myocardial depressants (propofol bolus, ≥1 MAC volatile) |
| Induction | Slow titrated GA (etomidate + ketamine + opioid); avoid high spinal/epidural; arterial line + CVC pre-induction; TOE intraoperatively |
Examiner's PearlPH definition: mPAP ≥20 mmHg. PAH (Group 1): pre-capillary, PVR >2 WU, PAWP ≤15. RV death spiral: ↑PVR → RV dilates → D-septum → ↓LV filling → ↓CO → ↓DBP → RV ischaemia → death. Avoid hypoxia/hypercapnia/N₂O/↑PEEP/vasodilation. Vasopressor of choice: vasopressin. Pulmonary vasodilator: inhaled NO.
References: Simonneau G et al. Eur Respir J 2019;53:1801913. Price LC et al. Eur Respir Rev 2010;19:35-42. ESC/ERS PH Guidelines 2022. Miller's Anaesthesia, 9th Ed.
"